Gastrointestinal Nursing is the leading journal for nurses working in gastroenterology, hepatology and stoma care.    The journal publishes original research, clinical reviews and case studies that have been peer-reviewed by leading experts in the field, as well as news and expert analysis on best practice, professional development and healthcare policy. Each of the ten issues a year touches on a range of topics, from inflammatory bowel disease (IBD), viral hepatitis and colorectal cancer to upper GI endoscopy, parenteral nutrition and irritable bowel syndrome (IBS).    Gastrointestinal Nursing aims to help specialist nurses improve the quality of life of patients by delivering care that is evidence-based, cost-effective and patient-centred.

Gastrointestinal Nursing is the leading journal for nurses working in gastroenterology, hepatology, and stoma care. The journal publishes original research, clinical reviews, and case studies that have been peer-reviewed by leading experts in the field, as well as news and expert analysis on best practices, professional development, and healthcare policy. Each of the ten issues a year covers a range of topics, from inflammatory bowel disease (IBD), viral hepatitis, and colorectal cancer to upper GI endoscopy, parenteral nutrition, and irritable bowel syndrome (IBS). Gastrointestinal Nursing aims to help specialist nurses improve the quality of life of patients by delivering care that is evidence-based, cost-effective, and patient-centered.

《Gastrointestinal Nursing》是专为从事胃肠病学、肝病学和造口护理的护士而设的领先期刊。该期刊发表经过领域内顶尖专家同行评审的原创研究、临床评论和案例研究，以及关于最佳实践、职业发展和医疗政策的新闻与专家分析。每年出版十期，涵盖从炎症性肠病（IBD）、病毒性肝炎和结直肠癌到上消化道内镜检查、肠外营养和肠易激综合症（IBS）等多个主题。《Gastrointestinal Nursing》的目标是帮助专业护士通过提供基于证据、具有成本效益和以患者为中心的护理，改善患者的生活质量。

Gastrointestinal Nursing

Wendi Harrison

The IBD clinical nurse specialist role: changes and challenges

炎症性肠病临床护理专家角色：变化与挑战

Background: Patient satisfaction is related to patients’ expectation of health services, which they use to satisfy their needs for maintaining health and curing disease. The management of inflammatory bowel disease (IBD) involves complex diagnostic and therapeutic approaches, in which nurses play a decisive role. The present study evaluated patients’ overall perception of the quality of nursing care received during biological therapy. Methods: The researchers recruited patients who underwent outpatient biological therapy for IBD at a health institution between October and December 2021. They evaluated patient satisfaction of nursing care using three sections of the Newcastle Satisfaction Nursing Scale (NSNS). Participants were categorised according to time of follow-up: long (&gt;12 months), short (≤12 months). Results: The researchers administered 234 questionnaires and enrolled 200 participants (response rate: 86.2%). The overall levels of satisfaction relating to scales A and B of the NSNS were 88.4 and 90.7, respectively. Patient loyalty was found to have a significant positive affect on satisfaction for scales A (90.5 versus 82.9, long versus short follow-up) and B (92.5 versus 86.0, long versus short follow-up) (p&lt;0.05). Conclusions: The level of patient satisfaction at the centre was excellent, indicating that the overall perception of nursing care was very high.

Daniele Napolitano

Antonello Cocchieri

Nicoletta Orgiana

Eleonora Durini

Martina Strazzeri

Caterina Fanali

Andrea Poscia

Franco Scaldaferri

Patient satisfaction with nursing care during biological therapy for inflammatory bowel disease: an observational study

炎症性肠病患者生物治疗期间护理满意度：一项观察性研究

A look at the new IBD UK national report on inflammatory bowel disease in the UK, which highlights the shortfalls in current practice that must be addressed.

Geraldine Cooper

The state of IBD care in the UK: why it is time for more investment

英国IBD护理现状：为何现在是加大投资的时候

Background: Inflammatory bowel disease (IBD) can increase the risk of pregnancy-related complications such as preterm birth, small for gestational age babies, gestational diabetes and caesarean section. Severe disease activity during pregnancy can further increase said complications. Pregnancy care pathways for women living with IBD may vary depending on the service provision available. While some women can have established relationships with IBD teams, others may have not. Aims and methods: This study aimed to understand the factors and influences that have shaped women's experiences of pregnancy when living with IBD, as well as explore components of maternity care pathways. Women's experiences were obtained through an online survey and a series of one-to-one interviews. Results: This mixed-methods study provides original first-hand insights into what women want from their IBD team during pregnancy, with novel themes identified regarding a need for information about what to expect about their disease activity during pregnancy and reassurance about medication use. Discussion: Without discussion of such possible disease activity in pregnancy, women may make assumptions based upon ‘hearsay’ or have expectations that may not be accurate within the context of their personal experience of disease severity. Women with IBD may also experience additional unnecessary negative psychological or physical effects if evidence-based information is not given about medication. Woman may stop taking medication, risking increased disease activity, or experience additional anxiety about the perceived effects that medication may have on their baby. Conclusions: The provision of specialist IBD care during pregnancy may vary according to service provider; however the IBD multidisciplinary team can be central to ensuring women receive optimal evidence-based care in a timely manner during pregnancy. This will help ensure women feel able to make informed decisions about their care, and avoid experiencing additional psychological and physical effects.

Helen Janiszewski

Lisa Younge

Joanne Cooper

Jane Coad

Gordon W Moran

Claire Greenaway

Elizabeth Bailey

What do women want from their inflammatory bowel disease team during pregnancy?

女性在怀孕期间对炎症性肠病团队有何期望？

Acute severe ulcerative colitis (ASUC) and Crohn's disease (CD) can present as medical emergencies that require immediate and coordinated care due to the risk of significant morbidity and mortality. This clinical review explores the assessment and management of inflammatory bowel disease emergencies, including ASUC, toxic megacolon, massive haemorrhage, intra-abdominal abscesses, and bowel obstruction. The review highlights the critical importance of prompt diagnosis, patient-centred care, and the integration of multidisciplinary teams (MDTs) in managing these complex cases. It also outlines the clinical approaches, necessary investigations, and both medical and surgical management strategies essential for optimising patient outcomes. The review emphasises the need for healthcare professionals to be equipped with the knowledge and confidence to manage these emergencies effectively, thus enhancing patient care and safety. This article does not aim to explore UC and CD in their entirety but rather aims to focus on the acute emergencies associated with these conditions.

Hasan Hazim Alsararatee

Oluwadamilola Ojo

Assessment, diagnosis and management of inflammatory bowel disease emergencies

炎症性肠病急症的评估、诊断与管理

Melissa McAlees

news

新闻

Sean Boyle

Expanding our focus

扩大我们的关注点

Background: Lynch syndrome is a genetic condition that significantly raises the risk of bowel cancer and increases the likelihood of other cancers, such as uterine and ovarian cancers. Aims: The study aimed to evaluate the characteristics of colorectal cancer (CRC) patients seen in a lynch syndrome (LS) clinic across the North East London Cancer Alliance (NELCA) region, and identify patient- and cancer-related features, such as location and staging. Method: This study used a population-based observational cohort analysis in the NELCA region, across three NHS trusts. The study was run between 24 January, 2023, and 23 January, 2024. Data on 28 CRC patients were collected, then reviewed in a colorectal genetic clinic. A total of 26 patients agreed to take part in LS testing; two of the cohort refused. Clinical-specific data were routinely collected following the patients’ initial clinical appointment. Prevalence of LS was determined and correlated with patient characteristics (sex, ethnic background and age) and attributes relating to their cancer diagnosis (tumour location, tumour size and spread into nearby tissue, as per TNM staging). Results: LS was diagnosed in 6 (23%) of the 26 patients that underwent testing. An increased likelihood of LS was associated with several features, including: T3 staging, a right-sided tumour location, and being of the male sex, a White ethnic background and between 41 to 60 years of age. Conclusions: The study demonstrates the continued importance of colorectal genetic clinics in detecting LS. It exemplifies how genetic clinics can improve LS diagnosis and why it is necessary to integrate LS clinics in CRC patient care.

Filipe Carvalho

Report on a colorectal Lynch syndrome clinic across the North-East London Cancer Alliance region

关于伦敦东北癌症联盟区域结直肠林奇综合征诊所的报告

Background: Faecal calprotectin (FC) is an easily applicable faecal surrogate marker of intestinal inflammation; it has provided a new means for objectively assessing disease activity in patients with various bowel diseases. In this study, the authors assessed levels of FC before colonoscopy preparation, during bowel cleansing and 1 week after colonoscopy. Methods: This cross-sectional study was conducted on 58 individuals referred to Razi Hospital, Rasht, Iran, for colonoscopy between 2021 and 2022. For all individuals, stool sampling was repeated three times before colonoscopy, during bowel preparation and 1 week after colonoscopy. All demographical and clinical data were collected through a questionnaire. FC results, colonoscopy and pathology findings were also recorded. Results: The mean age of the participants was 48.22±11.69 years and approximately 62.1% were female. There was no statistically significant difference between the average levels of FC before colonoscopy preparation, during bowel cleansing and 1 week after colonoscopy (P&gt;0.05). The average amount of FC at different time points was not significantly different in patients with abnormal histopathological results compared to individuals with normal findings (P&gt;0.05). Conclusions: The study findings suggest that bowel cleansing and colonoscopy do not significantly alter FC levels.

Farahnaz Joukar

Hadi Mohsenifar

Saman Maroufizadeh

Milad Shahdkar

Mahdi Orang Goorabzarmakhi

Mahmoud Khoshsorour

Fariborz Mansour-Ghanaei

Assessment of calprotectin levels preceding and succeeding colonoscopy

结肠镜检查前后钙卫蛋白水平的评估

A brief overview of recently published articles on gastroenterology, hepatology and stoma care

Nikki Welyczko

Journal scan

期刊扫描

ISSN	1479-5248, 2052-2835
h-index	16

Publication Information	Publisher: MA Healthcare Ltd，Publishing cycle: ，Journal Type: journal，Open Access Journals: No
Basic data	Year of publication: 2006，Proportion of original research papers: 0.00%，Self Citation Rate:N.A.， Gold OA Rate: 0.00%

Gastrointestinal Nursing

Journal Citation Format

A journal article with 1 author

A journal article with 2 authors

A journal article with 3 authors

A journal article with 5 or more authors

Books Citation Format

Thesis Citation Format

Web sites Citation Format

Patent Citation Format

Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.

Share Submission Experience